← Back to catalogue

Seraclone® Anti-c (RH4)

FDA UDI

by Bio-Rad Medical Diagnostics GmbH

Identity

Trade Name
Seraclone® Anti-c (RH4) FDA UDI
Generic Name
Anti-C [RH004] red blood cell grouping IVD, antibody FDA UDI
Device Name
Blood Grouping Reagent Anti-c (RH4); Seraclone® Human Monoclonal (MS33); for tube test; 5ml FDA UDI
Model / Reference
802346100 FDA UDI
Description
Blood Grouping Reagent Anti-c (RH4); Seraclone® Human Monoclonal (MS33); for tube test; 5ml FDA UDI

Identifiers

Catalog Number
802346100 FDA UDI
Primary DI / UDI-DI
07611969950461 FDA UDI
GMDN Term
Anti-C [RH004] red blood cell grouping IVD, antibody FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

Yes

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Anti-C [RH004] red blood cell grouping IVD, antibody

Seraclone® Anti-c (RH4) by Bio-Rad Medical Diagnostics GmbH — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Anti-C [RH004] red blood cell grouping IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Bio-Rad Medical Diagnostics GmbH

Sources (1)

  • FDA UDI 4744c6bd-554e-4d51-af1f-f4b29cdf2928 36 fields · synced May 30, 2026